No. of Pages: 224 | Report Code: TIPRE00022771 | Category: Technology, Media and Telecommunications
1.1 Report Guidance
1.2 Market Segmentation
2.1 Key Insights
2.2 Market Attractiveness
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4.1 4.1 Overview
4.2 Ecosystem Analysis
4.2.1 Software/Service Providers:
4.2.2 System Integrators:
4.2.3 Regulatory Bodies:
4.2.4 End-Users:
4.2.5 List of Vendors in the Value Chain
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6.1 Europe Pharmacovigilance and Drug Safety Software Market Revenue (US$ Thousand), 2021–2031
6.2 Europe Pharmacovigilance and Drug Safety Software Market Forecast Analysis
7.1 Software
7.1.1 Overview
7.1.2 Software: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
7.2 Services
7.2.1 Overview
7.2.2 Services: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
8.1 Cloud
8.1.1 Overview
8.1.2 Cloud: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
8.2 On Premises
8.2.1 Overview
8.2.1 On Premises: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
9.1 Large Enterprises
9.1.1 Overview
9.1.2 Large Enterprises: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
9.2 SMEs
9.2.1 Overview
9.2.1 SMEs: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
10.1 Standard
10.1.1 Overview
10.1.2 Standard: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
10.2 Customized
10.2.1 Overview
10.2.1 Customized: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.1 Signal and Risk Management
11.1.1 Overview
11.1.2 Signal and Risk Management: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.2 Issue Tracking and Adverse Event Tracking
11.2.1 Overview
11.2.2 Issue Tracking and Adverse Event Tracking: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.3 Case Management
11.3.1 Overview
11.3.2 Case Management: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.4 Clinical Safety Management and Clinical Trial Safety
11.4.1 Overview
11.4.1 Clinical Safety Management and Clinical Trial Safety: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.5 Quality and Compliance
11.5.1 Overview
11.5.1 Quality and Compliance: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.6 Medical Writing
11.6.1 Overview
11.6.1 Medical Writing: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.7 Audit Support and Training Compliance
11.7.1 Overview
11.7.1 Audit Support and Training Compliance: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.8 Healthcare Analytics
11.8.1 Overview
11.8.1 Healthcare Analytics: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
11.9 Others
11.9.1 Overview
11.9.1 Others: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
12.1 Pharmaceutical and Biotechnology Companies
12.1.1 Overview
12.1.2 Pharmaceutical and Biotechnology Companies: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
12.2 Contract Research Organizations
12.2.1 Overview
12.2.1 Contract Research Organizations: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
12.3 Business Process Outsourcing (BPO) Firms
12.3.1 Overview
12.3.1 Business Process Outsourcing (BPO) Firms: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
12.4 Others
12.4.1 Overview
12.4.1 Others: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
13.1 Europe
13.1.1 Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
13.1.1.1 Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
13.1.1.2 Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
13.1.1.2.1 Germany: Europe Pharmacovigilance and Drug Safety Software Market Share – by Offering
13.1.1.2.2 Germany: Europe Pharmacovigilance and Drug Safety Software Market Share – by Deployment
13.1.1.2.3 Germany: Europe Pharmacovigilance and Drug Safety Software Market Share – by Enterprise Size
13.1.1.2.4 Germany: Europe Pharmacovigilance and Drug Safety Software Market Share – by Form
13.1.1.2.5 Germany: Europe Pharmacovigilance and Drug Safety Software Market Share – by Functionality
13.1.1.2.6 Germany: Europe Pharmacovigilance and Drug Safety Software Market Share – by End User
13.1.1.3 France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
13.1.1.3.1 France: Europe Pharmacovigilance and Drug Safety Software Market Share – by Offering
13.1.1.3.2 France: Europe Pharmacovigilance and Drug Safety Software Market Share – by Deployment
13.1.1.3.3 France: Europe Pharmacovigilance and Drug Safety Software Market Share – by Enterprise Size
13.1.1.3.4 France: Europe Pharmacovigilance and Drug Safety Software Market Share – by Form
13.1.1.3.5 France: Europe Pharmacovigilance and Drug Safety Software Market Share – by Functionality
13.1.1.3.6 France: Europe Pharmacovigilance and Drug Safety Software Market Share – by End User
13.1.1.4 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
13.1.1.4.1 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Share – by Offering
13.1.1.4.2 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Share – by Deployment
13.1.1.4.3 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Share – by Enterprise Size
13.1.1.4.4 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Share – by Form
13.1.1.4.5 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Share – by Functionality
13.1.1.4.6 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Share – by End User
13.1.1.5 Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
13.1.1.5.1 Italy: Europe Pharmacovigilance and Drug Safety Software Market Share – by Offering
13.1.1.5.2 Italy: Europe Pharmacovigilance and Drug Safety Software Market Share – by Deployment
13.1.1.5.3 Italy: Europe Pharmacovigilance and Drug Safety Software Market Share – by Enterprise Size
13.1.1.5.4 Italy: Europe Pharmacovigilance and Drug Safety Software Market Share – by Form
13.1.1.5.5 Italy: Europe Pharmacovigilance and Drug Safety Software Market Share – by Functionality
13.1.1.5.6 Italy: Europe Pharmacovigilance and Drug Safety Software Market Share – by End User
13.1.1.6 Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
13.1.1.6.1 Spain: Europe Pharmacovigilance and Drug Safety Software Market Share – by Offering
13.1.1.6.2 Spain: Europe Pharmacovigilance and Drug Safety Software Market Share – by Deployment
13.1.1.6.3 Spain: Europe Pharmacovigilance and Drug Safety Software Market Share – by Enterprise Size
13.1.1.6.4 Spain: Europe Pharmacovigilance and Drug Safety Software Market Share – by Form
13.1.1.6.5 Spain: Europe Pharmacovigilance and Drug Safety Software Market Share – by Functionality
13.1.1.6.6 Spain: Europe Pharmacovigilance and Drug Safety Software Market Share – by End User
13.1.1.7 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
13.1.1.7.1 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Share – by Offering
13.1.1.7.2 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Share – by Deployment
13.1.1.7.3 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Share – by Enterprise Size
13.1.1.7.4 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Share – by Form
13.1.1.7.5 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Share – by Functionality
13.1.1.7.6 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Share – by End User
14.1 Heat Map Analysis by Key Players
14.2 Company Positioning and Concentration
15.1 Overview
15.2 Market Initiative
15.3 Partnerships and Collaborations
16.1 ArisGlobal LLC
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Max Application
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Oracle Corp
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 Veeva Systems Inc
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 IQVIA Holdings Inc
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 ICON Plc
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Cognizant Technology Solutions Corp
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Accenture Plc
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 Syneos Health Inc
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 Genpact Ltd.
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
16.11 AB Cube S.A.S.
16.11.1 Key Facts
16.11.2 Business Description
16.11.3 Products and Services
16.11.4 Financial Overview
16.11.5 SWOT Analysis
16.11.6 Key Developments
16.12 Laboratory Corp of America Holdings
16.12.1 Key Facts
16.12.2 Business Description
16.12.3 Products and Services
16.12.4 Financial Overview
16.12.5 SWOT Analysis
16.12.6 Key Developments
16.13 Parexel International Corp
16.13.1 Key Facts
16.13.2 Business Description
16.13.3 Products and Services
16.13.4 Financial Overview
16.13.5 SWOT Analysis
16.13.6 Key Developments
16.14 Qinecsa Solutions
16.14.1 Key Facts
16.14.2 Business Description
16.14.3 Products and Services
16.14.4 Financial Overview
16.14.5 SWOT Analysis
16.14.6 Key Developments
16.15 Clinevo Technologies
16.15.1 Key Facts
16.15.2 Business Description
16.15.3 Products and Services
16.15.4 Financial Overview
16.15.5 SWOT Analysis
16.15.6 Key Developments
17.1 About Us
17.2 List of Abbreviations
Table 1. Europe Pharmacovigilance and Drug Safety Software Market Segmentation
Table 2. List of Vendors
Table 3. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Table 4. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand) – by Offering
Table 5. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand) – by Deployment
Table 6. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand) – by Enterprise Size
Table 7. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand) – by Form
Table 8. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand) – by Functionality
Table 9. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand) – by End User
Table 10. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand) – by Country
Table 11. Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Offering
Table 12. Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Deployment
Table 13. Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Enterprise Size
Table 14. Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Form
Table 15. Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Functionality
Table 16. Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by End User
Table 17. France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Offering
Table 18. France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Deployment
Table 19. France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Enterprise Size
Table 20. France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Form
Table 21. France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Functionality
Table 22. France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by End User
Table 23. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Offering
Table 24. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Deployment
Table 25. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Enterprise Size
Table 26. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Form
Table 27. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Functionality
Table 28. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by End User
Table 29. Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Offering
Table 30. Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Deployment
Table 31. Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Enterprise Size
Table 32. Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Form
Table 33. Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Functionality
Table 34. Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by End User
Table 35. Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Offering
Table 36. Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Deployment
Table 37. Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Enterprise Size
Table 38. Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Form
Table 39. Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Functionality
Table 40. Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by End User
Table 41. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Offering
Table 42. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Deployment
Table 43. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Enterprise Size
Table 44. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Form
Table 45. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by Functionality
Table 46. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021 – 2031 (US$ Thousand) – by End User
Table 47. List of Abbreviations
Figure 1. Europe Pharmacovigilance and Drug Safety Software Market Segmentation – Country
Figure 2. Europe Pharmacovigilance and Drug Safety Software Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Pharmacovigilance and Drug Safety Software Market Revenue (US$ Thousand), 2021–2031
Figure 5. Europe Pharmacovigilance and Drug Safety Software Market Share (%) – by Offering (2023 and 2031)
Figure 6. Software: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 7. Services: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 8. Europe Pharmacovigilance and Drug Safety Software Market Share (%) – by Deployment (2023 and 2031)
Figure 9. Cloud: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 10. On Premises: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 11. Europe Pharmacovigilance and Drug Safety Software Market Share (%) – by Enterprise Size (2023 and 2031)
Figure 12. Large Enterprises: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 13. SMEs: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 14. Europe Pharmacovigilance and Drug Safety Software Market Share (%) – by Form (2023 and 2031)
Figure 15. Standard: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 16. Customized: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 17. Europe Pharmacovigilance and Drug Safety Software Market Share (%) – by Functionality (2023 and 2031)
Figure 18. Signal and Risk Management: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 19. Issue Tracking and Adverse Event Tracking: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 20. Case Management: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 21. Clinical Safety Management and Clinical Trial Safety: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 22. Quality and Compliance: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 23. Medical Writing: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 24. Audit Support and Training Compliance: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 25. Healthcare Analytics: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 26. Others: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 27. Europe Pharmacovigilance and Drug Safety Software Market Share (%) – by End User (2023 and 2031)
Figure 28. Pharmaceutical and Biotechnology Companies: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 29. Contract Research Organizations: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 30. Business Process Outsourcing (BPO) Firms: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 31. Others: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021–2031 (US$ Thousand)
Figure 32. Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 33. Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021– 2031 (US$ Thousand)
Figure 34. France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021– 2031 (US$ Thousand)
Figure 35. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021– 2031 (US$ Thousand)
Figure 36. Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021– 2031 (US$ Thousand)
Figure 37. Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021– 2031 (US$ Thousand)
Figure 38. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021– 2031 (US$ Thousand)
Figure 39. Heat Map Analysis by Key Players
Figure 40. Company Positioning and Concentration
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Pharmacovigilance and Drug Safety Software Market
